METHYL 2-METHYL-2-(1H-1,2,4-TRIAZOL-1-YL)PROPANOATE
- $118 - $400
- Product name: METHYL 2-METHYL-2-(1H-1,2,4-TRIAZOL-1-YL)PROPANOATE
- CAS: 885949-78-0
- MF: C7H11N3O2
- MW: 169.18
- EINECS:
- MDL Number:MFCD06659569
- Synonyms:METHYL 2-METHYL-2-(1H-1,2,4-TRIAZOL-1-YL)PROPANOATE;1H-1,2,4-Triazole-1-acetic acid, α,α-dimethyl-, methyl ester
4 prices
Selected condition:
Brand
- Crysdot
- Matrix Scientific
Package
- 500mg
- 1g
- 5g
- 10g
- ManufacturerCrysdot
- Product numberCD11032132
- Product descriptionMethyl2-methyl-2-(1H-1,2,4-triazol-1-yl)propanoate 95+%
- Packaging10g
- Price$400
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number045166
- Product descriptionMethyl 2-methyl-2-(1H-1,2,4-triazol-1-yl)-propanoate >95%
- Packaging500mg
- Price$118
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number045166
- Product descriptionMethyl 2-methyl-2-(1H-1,2,4-triazol-1-yl)-propanoate >95%
- Packaging1g
- Price$151
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number045166
- Product descriptionMethyl 2-methyl-2-(1H-1,2,4-triazol-1-yl)-propanoate >95%
- Packaging5g
- Price$346
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Crysdot | CD11032132 | Methyl2-methyl-2-(1H-1,2,4-triazol-1-yl)propanoate 95+% | 10g | $400 | 2021-12-16 | Buy |
Matrix Scientific | 045166 | Methyl 2-methyl-2-(1H-1,2,4-triazol-1-yl)-propanoate >95% | 500mg | $118 | 2021-12-16 | Buy |
Matrix Scientific | 045166 | Methyl 2-methyl-2-(1H-1,2,4-triazol-1-yl)-propanoate >95% | 1g | $151 | 2021-12-16 | Buy |
Matrix Scientific | 045166 | Methyl 2-methyl-2-(1H-1,2,4-triazol-1-yl)-propanoate >95% | 5g | $346 | 2021-12-16 | Buy |
Properties
Boiling point :96°/1mm
Density :1.17±0.1 g/cm3(Predicted)
pka :2.29±0.10(Predicted)
Density :1.17±0.1 g/cm3(Predicted)
pka :2.29±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|